A phase I clinical trial on intratumoral administration of autologous CD1c(BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma

Activiteit: Talk or presentation at a conference

Periode7 feb 2020
EvenementstitelBACR Annual Meeting 2020: Cancer metastasis: From bedside to bench
EvenementstypeConference
Conferentienummer26th
LocatieBrussels, Belgium
Mate van erkenningNational